LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy.
Schwab K, Frahm S, Magbagbeolu M, Horsley D, Goatman EA, Melis V, Theuring F, Ishaq A, Storey JMD, Harrington CR, Wischik CM, Riedel G.
Schwab K, et al. Among authors: harrington cr.
Eur J Pharmacol. 2024 May 5;970:176505. doi: 10.1016/j.ejphar.2024.176505. Epub 2024 Mar 18.
Eur J Pharmacol. 2024.
PMID: 38503400
Free article.